![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
K Matsunaga and RF Furchgott
Department of Pharmacology, State University of New York, Brooklyn.
In a perfusion-superfusion system, an endothelium-free ring of rabbit thoracic aorta precontracted with phenylephrine was used to bioassay relaxing activity. As previously reported, when NaNO2 (1 mM) was added to the standard Krebs' solution (37 degrees C oxygenated, containing 30 microM EDTA), irradiation of the solution with long wavelength ultraviolet light, while it was perfusing through a glass tube proximal to the bioassay ring, resulted in a small degree of relaxation of the ring, and this relaxation was markedly potentiated when superoxide dismutase (SOD, 10 U/ml) was also present in the solution. The full potentiation by SOD of the relaxation produced by photoactivation of NO2- was matched by cytochrome c (30 microM), MnCl2 (30 microM) and CuCl2 (100 microM), all of which are scavengers of superoxide (O2-). No potentiation was produced by catalase (1,000 U/ml), ZnCl2 (100 microM) and boiled SOD. Also, CuCl2, when its concentration was no greater than that of the EDTA in the Krebs' solution, failed to potentiate the relaxation. These results are consistent with our earlier conclusion that the relaxant produced by irradiation of NO2- is NO and that it is normally inactivated rapidly by O2- also present in the irradiated perfusion fluid. When EDTA was omitted from the perfusing Krebs' solution, photoactivation of NO2- in the solution produced a very large relaxation of the bioassay ring, which was not enhanced by addition of SOD or other O2- scavengers.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
|
|
 |
|
  G. Zhang, F. Zhang, R. Muh, F. Yi, K. Chalupsky, H. Cai, and P.-L. Li Autocrine/paracrine pattern of superoxide production through NAD(P)H oxidase in coronary arterial myocytes Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H483 - H495. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Rodriguez, R. E. Maloney, T. Rassaf, N. S. Bryan, and M. Feelisch Chemical nature of nitric oxide storage forms in rat vascular tissue PNAS, January 7, 2003; 100(1): 336 - 341. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. S. Hussain, N. H. Crispino, B. E. McLaughlin, J. F. Brien, G. S. Marks, and K. Nakatsu Glyceryl Trinitrate-Induced Vasodilation Is Inhibited by Ultraviolet Irradiation Despite Enhanced Nitric Oxide Generation: Evidence for Formation of a Nitric Oxide Conjugate J. Pharmacol. Exp. Ther., May 1, 1999; 289(2): 895 - 900. [Abstract] [Full Text]
|
|
|
|
|
|
E. Colombari, R. L. Davisson, R. A. Shaffer, W. T. Talman, and S. J. Lewis Hemodynamic effects of L-glutamate in NTS of conscious rats: a possible role of vascular nitrosyl factors Am J Physiol Heart Circ Physiol, April 1, 1998; 274(4): H1066 - H1074. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. L. Davisson, R. A. Shaffer, A. K. Johnson, and S. J. Lewis Use-Dependent Loss of Active Sympathetic Neurogenic Vasodilation After Nitric Oxide Synthase Inhibition in Conscious Rats: Evidence for the Presence of Preformed Stores of Nitric Oxide–Containing Factors Hypertension, September 1, 1996; 28(3): 347 - 353. [Abstract] [Full Text]
|
|
|
|
|
|
R. L. Davisson, J. N. Bates, A. K. Johnson, and S. J. Lewis Use-Dependent Loss of Acetylcholine- and Bradykinin-Mediated Vasodilation After Nitric Oxide Synthase Inhibition: Evidence for Preformed Stores of Nitric Oxide–Containing Factors in Vascular Endothelial Cells Hypertension, September 1, 1996; 28(3): 354 - 360. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
